Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
Status:
Completed
Trial end date:
2018-05-09
Target enrollment:
Participant gender:
Summary
This research study is studying a chemotherapy as a possible treatment for recurrent
glioblastoma that has not responded to bevacizumab. The name of the study drug involved in
this study is Ponatinib.